Parsippany, NJ, United States of America

Wenshan Hao

This inventor holds 3 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: Jn Therapeutics, Neomics Pharmaceuticals LLC, Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.. Active years: 2020-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Wenshan Hao. Retrieved from https://idiyas.com/inventor/wenshan-hao

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 3.3

ph-index = 1


Company Filing History:


Years Active: 2020-2025

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Wenshan Hao: Innovator in Biopharmaceuticals

Introduction

Wenshan Hao is a notable inventor based in Parsippany, NJ (US). He has made significant contributions to the field of biopharmaceuticals, holding a total of 3 patents. His work focuses on innovative therapies that address critical health challenges.

Latest Patents

One of Wenshan Hao's latest patents is titled "Chimeric antigen receptor comprising BCMA nanobody linked to a chimeric intracellular signaling domain." This application relates to functionally improved third generation BCMA-CARs, which comprise modified intracellular co-stimulatory domains. These advancements can be utilized in adoptive cell therapy, particularly in the treatment of diseases and disorders such as cancer. Another significant patent is for "Substituted imidazo[1,2-a]pyridin-2-ylamine compounds, and pharmaceutical compositions and methods of use thereof." This patent provides substituted imidazo[1,2-a]pyridin-2-ylamine compounds and pharmaceutical compositions, along with methods for treating, preventing, or ameliorating symptoms of Janus kinase-mediated diseases.

Career Highlights

Wenshan Hao has worked with several prominent companies in the biopharmaceutical sector. Notably, he has been associated with Neomics Pharmaceuticals LLC and Shanghai Fudan-Zhangjiang Bio-pharmaceutical Co., Ltd. His expertise and innovative approach have made him a valuable asset in these organizations.

Collaborations

Throughout his career, Wenshan has collaborated with talented individuals, including Jin Li and Sean Chen. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.

Conclusion

Wenshan Hao's contributions to biopharmaceutical innovations are noteworthy. His patents reflect a commitment to improving therapeutic options for patients facing serious health conditions. His work continues to inspire advancements in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…